Models of hearts, arteries, bones and brains are 3-D printed out of biological materials
As of this month, over 4,000 Americans are on the waiting list to receive a heart transplant. With failing hearts, these patients have no other options; heart tissue, unlike other parts of the body, is unable to heal itself once it is damaged. Fortunately, recent work by a group at Carnegie Mellon could one day lead to a world in which transplants are no longer necessary to repair damaged organs.
“We’ve been able to take MRI images of coronary arteries and 3-D images of embryonic hearts and 3-D bioprint them with unprecedented resolution and quality out of very soft materials like collagens, alginates and fibrins,” said Adam Feinberg, an associate professor of Materials Science and Engineering and Biomedical Engineering at Carnegie Mellon University. Feinberg leads the Regenerative Biomaterials and Therapeutics Group, and the group’s study was published in the October 23 issue of the journal Science Advances. A demonstration of the technology can be viewed online.
“As excellently demonstrated by Professor Feinberg’s work in bioprinting, our CMU researchers continue to develop novel solutions like this for problems that can have a transformational effect on society,” said Jim Garrett, Dean of Carnegie Mellon’s College of Engineering. “We should expect to see 3-D bioprinting continue to grow as an important tool for a large number of medical applications.”
Traditional 3-D printers build hard objects typically made of plastic or metal, and they work by depositing material onto a surface layer-by-layer to create the 3-D object. Printing each layer requires sturdy support from the layers below, so printing with soft materials like gels has been limited.
“3-D printing of various materials has been a common trend in tissue engineering in the last decade, but until now, no one had developed a method for assembling common tissue engineering gels like collagen or fibrin,” said TJ Hinton, a graduate student in biomedical engineering at Carnegie Mellon and lead author of the study.
“The challenge with soft materials — think about something like Jello that we eat — is that they collapse under their own weight when 3-D printed in air,” explained Feinberg. “So we developed a method of printing these soft materials inside a support bath material. Essentially, we print one gel inside of another gel, which allows us to accurately position the soft material as it’s being printed, layer-by-layer.”
One of the major advances of this technique, termed FRESH, or “Freeform Reversible Embedding of Suspended Hydrogels,” is that the support gel can be easily melted away and removed by heating to body temperature, which does not damage the delicate biological molecules or living cells that were bioprinted. As a next step, the group is working towards incorporating real heart cells into these 3-D printed tissue structures, providing a scaffold to help form contractile muscle.
Bioprinting is a growing field, but to date, most 3-D bioprinters have cost over $100,000 and/or require specialized expertise to operate, limiting wider-spread adoption. Feinberg’s group, however, has been able to implement their technique on a range of consumer-level 3-D printers, which cost less than $1,000 by utilizing open-source hardware and software.
The Latest on: 3-D bioprinting
via Google News
The Latest on: 3-D bioprinting
- Demand for 3D Bioprinting Market to Witness Rapid Surge During the Period 2015 - 2021on August 3, 2020 at 7:48 am
Aug 03, 2020 (MARKITWIRED via COMTEX) -- The demand for 3D bioprinting has increased significantly, as it is employed for developing organ and tissue constructs that are used scaffolds ...
- 3D Bioprinting Market Size, Share, Growth, Trends, Scope and Forecast 2020 - 2027on August 1, 2020 at 4:53 am
As per Vision Research Report, the global 3D bioprinting market size is projected to garner USD 4.1 billion by 2027, expanding at a CAGR of 17.3% from ...
- Aussie startup Inventia could revolutionize skin regeneration with 3D bioprinting roboton July 31, 2020 at 3:17 pm
Established in Sydney in 2013, Inventia is a privately owned company whose bioprinting technology originally was designed to build 3D cell structures to test different cancer therapies. Most companies ...
- 3-D printed organs aid vaccine testingon July 30, 2020 at 8:06 pm
While use of the technique in humans is years away, researchers are honing the methods to test drugs and more.
- A Possible Weapon Against the Pandemic: Printing Human Tissueon July 27, 2020 at 2:26 am
As shortages of personal protective equipment persist during the coronavirus pandemic, 3-D printing has helped to alleviate some of the gaps. But Anthony Atala, the director of the Wake Forest ...
- KFC Is 3D-Printing Chicken Nuggets. Would You Eat Them?on July 24, 2020 at 5:06 pm
KFC is partnering with a Moscow-based firm, 3D Bioprinting Solutions, to bring the chicken nuggets to life. The companies expect to test out the final product this fall. Kentucky Fried Chicken could ...
- Take a big bite into KFC's new plan for edible, 3D-printed chicken nuggetson July 24, 2020 at 8:46 am
Culinary scientists have been trying to concoct the "meat of the future" for decades, and now the fast-food icon KFC is stuffing money into a new partnership with Russian startup 3D Bioprinting ...
- KFC tests 3D printed nuggets on Russianson July 24, 2020 at 3:31 am
In Putin's Russia KFC thinks you are finger licking good. KFC will test chicken nuggets made with 3D bioprinting technology in Moscow, Russia the chain announced in a July 16 press release. The ...
- Nuggets of the future: KFC to test 3-D printed chicken this fallon July 23, 2020 at 6:46 am
But a new effort in Russia might just be the Louisville-based company's most ambitious project yet, reports Louisville Business First.KFC is launching the development of innovative 3D bioprinting ...
via Bing News